Chemical identity

Raltegravir EP Impurity D/ Raltegravir Oxalyl Analog

CAS 1064706-98-4 · C18H19FN4O6

01Identity

Identifiers and names for this exact compound. Empty fields are left unassigned.

Lazychem IDLC-26660
PubChem CID54737244
NameRaltegravir EP Impurity D/ Raltegravir Oxalyl Analog
CAS RN1064706-98-4
Molecular formulaC18H19FN4O6
Molecular weight406.37 g/mol
IUPAC name2-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-ylamino)-2-oxoacetic acid
InChIKeySWHOUCNLLYIBFG-UHFFFAOYSA-N

02Structure identifiers

Two-dimensional chemical structure of Raltegravir EP Impurity D/ Raltegravir Oxalyl Analog, CAS 1064706-98-4
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aromatic atoms, includes aliphatic carbon, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres0
Unassigned stereocentres0
Ring count2
Secondary amines0
Tertiary amines0
N-methyl amine sites0
SMILESCC(C)(C1=NC(=C(C(=O)N1C)O)C(=O)NCC2=CC=C(C=C2)F)NC(=O)C(=O)O
InChINot listed
Formula from structureC18H19FN4O6
Molecular weight from structure406.37 g/mol

03India status for this compound

These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.

NDPS / RCSNO EXACT MATCH FOUNDCAS 1064706-98-4 has no exact match in the reviewed published schedule.
SCOMETNO EXACT REVIEWED CAS MATCHCAS 1064706-98-4 has no exact match in the reviewed SCOMET list.
Review date2026-08-01Recheck the current official instruments for the material, concentration, activity and date in question.

04Names and relationships

Associated parent compound

Raltegravir

View API and impurity family

Other names

  • Raltegravir EP Impurity D
  • Raltegravir Oxalyl Analog
  • 2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) 2-(2-Amino-2-oxoacetic Acid) Raltegravir
  • 1064706-98-4
  • VCB1FAU7R0
  • UNII-VCB1FAU7R0
  • 2-((2-(4-((4-Fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)amino)-2-oxoacetic acid
  • 2-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-ylamino]-2-oxoacetic acid
  • DES(5-methyl-1,3,4-oxadiazol)-oxalo-raltegravir
  • Raltegravir potassium impurity D [EP]
  • N-(2-(4-(((4-Fluorophenyl)methyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)oxamic acid
  • {[2-(4-{[(4-fluorophenyl)methyl]carbamoyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]carbamoyl}formic acid

05Documented history

Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.

No dated history available

No verified discovery, first report, occurrence, use or issue event is currently available for this identity.

06Sources